These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
407 related items for PubMed ID: 8704185
1. Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma. Billadeau D, Van Ness B, Kimlinger T, Kyle RA, Therneau TM, Greipp PR, Witzig TE. Blood; 1996 Jul 01; 88(1):289-96. PubMed ID: 8704185 [Abstract] [Full Text] [Related]
2. Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myeloma. Paiva B, Pérez-Andrés M, Vídriales MB, Almeida J, de las Heras N, Mateos MV, López-Corral L, Gutiérrez NC, Blanco J, Oriol A, Hernández MT, de Arriba F, de Coca AG, Terol MJ, de la Rubia J, González Y, Martín A, Sureda A, Schmidt-Hieber M, Schmitz A, Johnsen HE, Lahuerta JJ, Bladé J, San-Miguel JF, Orfao A, GEM (Grupo Español de MM)/PETHEMA (Programa para el Estudio de la Terapéutica en Hemopatías Malignas), Myeloma Stem Cell Network (MSCNET). Leukemia; 2011 Apr 01; 25(4):697-706. PubMed ID: 21252988 [Abstract] [Full Text] [Related]
3. Immunoglobulin gene rearrangement in plasma cell dyscrasias: detection of small clonal cell populations in peripheral blood and bone marrow. Fend F, Weyrer K, Drach J, Schwaiger A, Umlauft F, Grünewald K. Leuk Lymphoma; 1993 Jun 01; 10(3):223-9. PubMed ID: 8220121 [Abstract] [Full Text] [Related]
4. Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis. Rajkumar SV, Mesa RA, Fonseca R, Schroeder G, Plevak MF, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE, Gertz MA, Kyle RA, Russell SJ, Greipp PR. Clin Cancer Res; 2002 Jul 01; 8(7):2210-6. PubMed ID: 12114422 [Abstract] [Full Text] [Related]
5. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia. Rasillo A, Tabernero MD, Sánchez ML, Pérez de Andrés M, Martín Ayuso M, Hernández J, Moro MJ, Fernández-Calvo J, Sayagués JM, Bortoluci A, San Miguel JF, Orfao A. Cancer; 2003 Feb 01; 97(3):601-9. PubMed ID: 12548602 [Abstract] [Full Text] [Related]
6. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution. Magnano L, Fernández de Larrea C, Elena M, Cibeira MT, Tovar N, Aróstegui JI, Pedrosa F, Rosiñol L, Filella X, Yagüe J, Bladé J. Clin Lymphoma Myeloma Leuk; 2016 Jun 01; 16(6):e71-7. PubMed ID: 27013181 [Abstract] [Full Text] [Related]
7. Comparison of interleukin-1 beta expression by in situ hybridization in monoclonal gammopathy of undetermined significance and multiple myeloma. Lacy MQ, Donovan KA, Heimbach JK, Ahmann GJ, Lust JA. Blood; 1999 Jan 01; 93(1):300-5. PubMed ID: 9864174 [Abstract] [Full Text] [Related]
8. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma. Ocqueteau M, Orfao A, Almeida J, Bladé J, González M, García-Sanz R, López-Berges C, Moro MJ, Hernández J, Escribano L, Caballero D, Rozman M, San Miguel JF. Am J Pathol; 1998 Jun 01; 152(6):1655-65. PubMed ID: 9626070 [Abstract] [Full Text] [Related]
9. Clonal plasma cells from monoclonal gammopathy of undetermined significance, multiple myeloma and plasma cell leukemia show different expression profiles of molecules involved in the interaction with the immunological bone marrow microenvironment. Pérez-Andrés M, Almeida J, Martín-Ayuso M, Moro MJ, Martín-Nuñez G, Galende J, Borrego D, Rodríguez MJ, Ortega F, Hernandez J, Moreno I, Domínguez M, Mateo G, San Miguel JF, Orfao A, Spanish Network on multiple myeloma (G03/136), Spanish Network of Cancer Research Centers (C03/10). Leukemia; 2005 Mar 01; 19(3):449-55. PubMed ID: 15674420 [Abstract] [Full Text] [Related]
10. Prevalence, mutational spectrum and clinical implications of clonal hematopoiesis of indeterminate potential in plasma cell dyscrasias. Testa S, Kumar J, Goodell AJ, Zehnder JL, Alexander KM, Sidana S, Arai S, Witteles RM, Liedtke M. Semin Oncol; 2022 Dec 01; 49(6):465-475. PubMed ID: 36503855 [Abstract] [Full Text] [Related]
11. MGUS and smoldering multiple myeloma: update on pathogenesis, natural history, and management. Rajkumar SV. Hematology Am Soc Hematol Educ Program; 2005 Dec 01; ():340-5. PubMed ID: 16304401 [Abstract] [Full Text] [Related]
13. A contribution to examination of propidium iodide and annexin V plasma cells indices in multiple myeloma. Scudla V, Ordeltova M, Bacovsky J, Vytrasova M, Sumna E, Martinek A, Horak P. Neoplasma; 2003 Dec 01; 50(5):363-71. PubMed ID: 14628090 [Abstract] [Full Text] [Related]
16. [Correlation between Morphological Typing and Monoclonality of Bone Marrow Plasma Cells and Its Diagnostic Value for High-Risk Smoldering Multiple Myeloma]. Xiao HJ, Wang QJ, Wu S, Dai XB, Zhuang YP. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Aug 01; 32(4):1146-1151. PubMed ID: 39192411 [Abstract] [Full Text] [Related]
17. The progression from MGUS to smoldering myeloma and eventually to multiple myeloma involves a clonal expansion of genetically abnormal plasma cells. López-Corral L, Gutiérrez NC, Vidriales MB, Mateos MV, Rasillo A, García-Sanz R, Paiva B, San Miguel JF. Clin Cancer Res; 2011 Apr 01; 17(7):1692-700. PubMed ID: 21325290 [Abstract] [Full Text] [Related]